Skip to main navigation Skip to search Skip to main content

A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia

  • JL Harousseau
  • , JE Lancet
  • , J Reiffers
  • , Bob Löwenberg
  • , X Thomas
  • , F Huguet
  • , P Fenaux
  • , S Zhang
  • , W Rackoff
  • , P De Porre
  • , R Stone

Research output: Contribution to journalArticleAcademicpeer-review

75 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5151-5156
Number of pages6
JournalBlood
Volume109
Issue number12
DOIs
Publication statusPublished - 2007

Research programs

  • EMC MM-02-41-03

Cite this